跳至主要内容
临床试验/NCT03267966
NCT03267966已完成不适用

Margin Status After Pancreaticoduodenectomy for Cancer. Results of a Multicentric Prospective Randomized Trial

Campus Bio-Medico University0 个研究点目标入组 168 人开始时间: 2013年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
168
主要终点
R1 resection rate

研究概览

简要总结

This multicentric prospective randomized controlled trial (RCT) compares the Leeds Pathology Protocol (LEEPP) with other "conventional" pathological protocol of PD specimen for periampullary cancer. Our aims were to evaluate the impact of the protocol and of the clearance on R1 rate and its prognostic value.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • pancreaticoduodenectomy for periampullary cancer

排除标准

  • diagnosis of neuroendocrine neoplasm;
  • previous pancreatic surgery;
  • frozen section of each transection margins not performed or presence of positive transection margins without further resection (R1 intraoperative resection);
  • presence of macroscopic residual tumor (R2 resection).

结局指标

主要结局

R1 resection rate

时间窗: 1 month

To evaluate difference in terms of R1 resection rates between study groups with 0-mm and 1-mm clearance

次要结局

  • pathological data(1 month)
  • oncological results(60 months)

研究者

发起方
Campus Bio-Medico University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gennaro Nappo

M.D.

Campus Bio-Medico University

相似试验